Hspooner
8 minutes ago
Hmmmm…. I guess you didn’t read the
memo, Ipilimumab is Yervoy BMS launched this treatment in 2011,as the 1st monoclonal antibody to target CTLA-4 and was indicated for melanoma, it works best with PD-1 inhibitors, but the side effects are horrible. BMS has been trying to find another indica